期刊文献+

低危型甲状腺癌诊疗争议 被引量:2

Controversies in the management of low-risk thyroid carcinoma
下载PDF
导出
摘要 低危型甲状腺癌的管理是目前甲状腺恶性肿瘤的焦点问题。虽然国内外陆续更新低危型甲状腺癌治疗策略指导,但临床诊疗中仍存在若干争议问题。选择临床主动观察、手术干预还是微创治疗成为低危型甲状腺癌治疗的争议所在,而热消融技术在低危型甲状腺癌的指证选择也存较多争议。因此,需要更多的研究来进一步探讨低危型甲状腺癌的最佳诊疗策略。在符合综合规范治疗的原则下,低危型甲状腺癌的治疗需要医患双方充分沟通,根据肿瘤本身以及患者家庭及社会因素(性格、工作、经济)、心理承受能力等多方面因素实现真正的个体化治疗策略。 Management of low-risk thyroid carcinoma has been the hotspot in the field of thyroid malignancy. Although the management guidelines for the patients with low-risk thyroid carcinoma standardize the diagnosis and therapy,there still are some controversies.Because of the favorable prognosis of low-risk thyroid carcinoma,it’s difficult to choose the optimal treatment from clinical follow-up,surgery in early stage or minimally invasive technology. However,radiofrequency ablation was controversial currently in the management of low-risk thyroid carcinoma more researches are necessary to guide the optimal treatment strategy for low-risk thyroid carcinoma. In line with the principle of comprehensive and standardized treatment,the treatment of low-risk thyroid cancer requires communication between doctors and patients,and a truly individualized treatment strategy based on the tumor,the patient’s social psychological factors and other factors.
作者 张婷婷 魏文俊 王宇 Zhang Tingting;Wei Wenjun;Wang Yu(Head&Neck Surgery Department of Fudan University Shanghai Cancer Center)
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2022年第11期1265-1267,共3页 Journal of Chongqing Medical University
基金 国家自然科学基金面上资助项目(编号:82072951) 上海市科委重点领域创新计划资助项目(编号:22Y21900100) 上海市申康中心促进市级医院临床技能与临床创新能力三年行动计划资助项目(编号:SHDC2020CR6003)。
关键词 低危型甲状腺癌 低危型甲状腺乳头状癌 治疗策略 主动观察 热消融 low-risk thyroid carcinoma low-risk papillary thyroid carcinoma treatment strategy active surveillance ablation
  • 相关文献

参考文献3

二级参考文献61

  • 1朱永学,王弘士,吴毅,嵇庆海,黄彩萍.甲状腺乳头状癌Ⅵ区淋巴结的归属[J].中华外科杂志,2004,42(14):867-869. 被引量:112
  • 2王家东,邓星程,金晓杰,周川,张淳,谢明,周佳青,钱敏飞.甲状腺肿瘤外科手术2228例临床分析[J].中华耳鼻咽喉头颈外科杂志,2005,40(4):295-299. 被引量:22
  • 3DeLellis RA, Lloyd RD, Heitz PU, et al. WHO: Pathology and Genetics. Turnouts of Endocrine Organs. Lyon: IARC Press, 2004.
  • 4Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland. The Gustave-Roussy Institute experience. Cancer, 1998,83:553-559.
  • 5Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A " normal" finding in Finland: a systematic autopsy study. Cancer, 1985,56:531-538.
  • 6Delides GS, Elemenoglou J, Lekkas J, et al. Occult thyroid carcinoma in a Greek population. Neoplasma, 1987,34 : 119-125.
  • 7Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg,1998, 85:252-254.
  • 8Roti E, Rossi R, Ttasforini G, et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab ,2006, 91:2171-2178.
  • 9Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg,2004, 28:1115- 1121.
  • 10Ozaki O, ho K, Kobayashi K, et al. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg, 1998,12:825-829.

共引文献496

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部